• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

16

CATEGORIES

  • 7
  • 7
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

10
11
12
32

PUBLISHED

0
3
9
32

PRODUCT TYPE

23
9

Search "Expression Analysis, Inc.-Deals & Alliances Report" returned 32 results.

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

May 2015
FROM

Laboratory Chemical Reagents - Global Strategic Business Report

This report analyzes the worldwide markets for Laboratory Chemical Reagents in US$ Million by the following Product Segments: Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene Expression,...

March 2012
FROM

Biomarkers, Tests and Trends for Drug R&D

This report is about the world market for biomarkers and tests used for drug R&D The study reviews and analyzes the market by examining biomarker related drug R&D spending, trends, major diseases, applications,...

February 2010
FROM

Biochips for Life Science Research, Diagnostics and Drug R&D

This research report is about the worldwide biochip tools, technologies and services market Biochips are also known as DNA microarrays, bioarrays, protein arrays, lab-on-a-chip, labchips, liquid arrays...

August 2009
FROM

CardioDx, Inc. - Strategic SWOT Analysis Review

CardioDx, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT...

March 2015
FROM

Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)

A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on a solid platform that allows multiple tests to be performed at the same time with increased efficiency and higher...

August 2011
FROM

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

July 2014
FROM

RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011

This report assesses the RNA interference market for drug R&D RNA interference (RNAi) has been hailed in the science media as the hottest technical breakthrough in bioscience in the last ten years A...

July 2007
FROM

Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets

GBI Research, a leading business intelligence provider, has released its latest research, entitled “Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber...

July 2012
FROM

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market.  As analyst Shara Rosen, R.T., MBA. details, in recent...

January 2013
FROM

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics (6th Edition)

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements...

December 2014
FROM

Hallmark Cards, Inc. - Strategic SWOT Analysis Review

Hallmark Cards, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed...

December 2013
FROM

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world,  in one complete volume. The report, The Worldwide Market for In Vitro...

July 2012
FROM

Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review

Affymetrix, Inc. (AFFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

April 2015
FROM

Genomics World Markets

Genomics is transforming the pharmaceutical industry Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics...

May 2008
FROM

WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic SWOT Analysis Review

WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

August 2014
FROM

Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review

Illumina, Inc. (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

March 2015
FROM

Sangamo BioSciences, Inc. (SGMO) - Financial and Strategic SWOT Analysis Review

Sangamo BioSciences, Inc. (SGMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

March 2015
FROM

Pharmacogenomics for Clinical Use and in Drug Development

Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth Applying pharmacogenomics would...

June 2009
FROM

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market Summary GBI Research's report, “Upstream Processing in Biopharmaceuticals...

March 2011
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group